International Immunology, Vol. 11, No. 4, 577-583,
April 1999
© 1999 Japanese Society for Immunology
Identification of antigenic escape variants in an immunodominant epitope of hepatitis C virus
The Blood Research Institute of The Blood Center, PO Box 2178, Milwaukee, WI 53201-2178, USA
Correspondence to: D. D. Eckels
Numerous investigators have postulated that one mechanism by which hepatitis C virus (HCV) may evade the immune system is through the formation of escape mutants. This hypothesis is based largely on the observed mutability of the viral genome resulting in evolution of diverse quasispecies over the course of infection. That such diversification is a product of viral RNA polymerase infidelity, immune-driven selection or a combination of the two processes has not been addressed. We have examined sequence variability in a specific segment of HCV RNA encoding a known immunodominant region of the viral helicase, amino acids 358–375 of the non-structural 3 protein. Using sequence-specific oligonucleotide probe hybridization and automated DNA sequencing, we report a high frequency of mutations, essentially all of which result in amino acid replacements. To assess the biological impact of such mutations, corresponding chemically synthesized peptides were compared to wild-type peptide in T cell proliferation assays. We observed that a sizeable fraction of such peptides stimulated attenuated or negligible levels of proliferation by peripheral T cells from a chronically infected patient. This observation is consistent with expectations for immune-mediated selection of escape variants at the epitope level. We postulate that such a mechanism may be important in the immunopathogenesis of HCV infections.
Keywords: hepatitis, T cells, epitopes, immunopathogenesis, synthetic peptides
Transmitting editor: T. Sasazuki
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. W. Tarr, A. M. Owsianka, D. Jayaraj, R. J. P. Brown, T. P. Hickling, W. L. Irving, A. H. Patel, and J. K. Ball Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33 J. Gen. Virol., November 1, 2007; 88(11): 2991 - 3001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Gerlach, A. Ulsenheimer, N. H. Gruner, M.-C. Jung, W. Schraut, C.-A. Schirren, M. Heeg, S. Scholz, K. Witter, R. Zahn, et al. Minimal T-Cell-Stimulatory Sequences and Spectrum of HLA Restriction of Immunodominant CD4+ T-Cell Epitopes within Hepatitis C Virus NS3 and NS4 Proteins J. Virol., October 1, 2005; 79(19): 12425 - 12433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Wieland and F. V. Chisari Stealth and Cunning: Hepatitis B and Hepatitis C Viruses J. Virol., August 1, 2005; 79(15): 9369 - 9380. [Full Text] [PDF]
|
|
|
|
 |
|
 L. K. McNeil and B. D. Evavold TCR Reserve: A Novel Principle of CD4 T Cell Activation by Weak Ligands J. Immunol., February 1, 2003; 170(3): 1224 - 1230. [Abstract] [Full Text] [PDF]
|
|